Ewing's sarcoma: Prognostic factors, disease control, and the reemerging role of surgical treatment

M. I. O'Connor, D. J. Pritchard

Research output: Contribution to journalReview article

47 Scopus citations

Abstract

Advances in the treatment of Ewing's sarcoma have been dramatic. Present treatment protocols control local disease by radiotherapy, surgery, or both; systemic spread is limited by aggressive multiagent chemotherapy. In patients with localized osseous Ewing's sarcoma, five-year survival rates now range from 54% to an estimated 74%. With late relapse not uncommon, control of the primary lesion is critical to long-term survival. Several studies now show improved local control and possibly improved survival of patients with surgical treatment of primary osseous Ewing's sarcoma.

Original languageEnglish (US)
Pages (from-to)78-87
Number of pages10
JournalClinical orthopaedics and related research
Issue number262
StatePublished - Jan 1 1991

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Ewing's sarcoma: Prognostic factors, disease control, and the reemerging role of surgical treatment'. Together they form a unique fingerprint.

  • Cite this